Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

OTHER(1)
1 unique interventions1 categories

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

Hepatotoxicity of Antituberculosis Therapy (HAT) Study
Chemical and Drug Induced Liver Injury
Principalinvestigator

Research Network

Collaboration Network

144 collaborators·150 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

First Affiliated Hospital of Harbin Medical University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ming Li

No.2 People's Hospital of Fuyang City

Related
2 trials

Shared therapeutic areas:

Drug-Induced Liver Disease

Worked with same sponsors:

Drug Induced Liver Disease Study Group
Similarity Score15%

Yimin Mao

RenJi Hospital

Related
4 trials

Shared therapeutic areas:

Drug-Induced Liver Disease

Worked with same sponsors:

Drug Induced Liver Disease Study Group
Similarity Score15%

Peng Hu

The Second Affiliated Hospital of Chongqing Medical University

Related
2 trials

Shared therapeutic areas:

Drug-Induced Liver Disease

Worked with same sponsors:

Drug Induced Liver Disease Study Group
Similarity Score15%

Jianwei Yang

Fujian Cancer Hospital

Related
3 trials

Shared therapeutic areas:

Drug-Induced Liver Disease

Worked with same sponsors:

Drug Induced Liver Disease Study Group
Similarity Score15%

Xiaoyan Wang

The Third Xiangya Hospital of Central South University

Related
2 trials

Shared therapeutic areas:

Drug-Induced Liver Disease

Worked with same sponsors:

Drug Induced Liver Disease Study Group
Similarity Score15%

Liaoyun Zhang

The First Affiliated Hospital of Shanxi Medical University

Related
2 trials

Shared therapeutic areas:

Drug-Induced Liver Disease

Worked with same sponsors:

Drug Induced Liver Disease Study Group
Similarity Score15%

Chengwei Chen

No.85 hospital of PLA

Related
2 trials

Shared therapeutic areas:

Drug-Induced Liver Disease

Worked with same sponsors:

Drug Induced Liver Disease Study Group
Similarity Score15%

Yan Huang

Xiangya Hospital of Central South University

Related
5 trials

Shared therapeutic areas:

Drug-Induced Liver Disease

Worked with same sponsors:

Drug Induced Liver Disease Study Group
Similarity Score15%

Qing Ye

Tianjin Third Central Hospital

Related
2 trials

Shared therapeutic areas:

Drug-Induced Liver Disease
Similarity Score15%

Guizhou Zou

The Second Hospital of Anhui Medical University

Related
2 trials

Shared therapeutic areas:

Drug-Induced Liver Disease

Worked with same sponsors:

Drug Induced Liver Disease Study Group
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02961413PrincipalInvestigator

A Prospective Cohort Study on Drug-induced Liver Injury in China(DILI-P)

Drug-induced Liver Injury
Recruiting
NCT04159441PrincipalInvestigator

Hepatotoxicity of Antituberculosis Therapy (HAT) Study

Chemical and Drug Induced Liver Injury
Unknown

All 2 trials loaded